Category: Panag Pharma Inc.

Read the original press release here. The Proposed Transaction is expected to provide Tetra: With the most robust Pharmaceutical and Natural Health Products (NHP) pipeline of any Cannabinoid company; With more pharmaceutical and natural health products; The ability to sell these products worldwide; and Access to Panag’s NHP portfolio which is not included in the…

Read the original article here. Halifax-based Panag Pharma, which is making pain-relief products from natural compounds found in cannabis plants, has agreed to be bought for as much as $27 million by Ontario’s Tetra Bio-Pharma. Based in the Ottawa suburb of Orleans, Tetra is a drug discovery company that specializes in developing treatments based on such compounds…

According to the Canadian Pain Society, one in five Canadians suffer from chronic pain and it costs more than cancer, heart disease, and HIV combined. Estimates place direct healthcare costs for Canada to be more than $6 billion per year and productivity costs related to job loss and sick days at $37 billion per year….